Awarded
Glycopyrronium-Kation 50,00 μg, entspricht Glycopyrronium bromid 62,55 μg Hartkapseln mit Pulver zur Inhalation St
- Buyer
- PBMG eG
- Winners
- Novartis Pharma GmbH
- Contract value
- no value published
- Bids received
- 2
- Published
- 2 Mar 2026
- Awarded
- 29 Dec 2025
- Contract start
- 1 Jul 2026
- Contract end
- 30 Jun 2027stated
- Region
- Hamburg (DE600)